Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 205,975.75 |
| Enterprise Value ($M) | 274,557.75 |
| Book Value ($M) | 12,594.00 |
| Book Value / Share | 7.12 |
| Price / Book | 16.36 |
| NCAV ($M) | -106,324.00 |
| NCAV / Share | -60.14 |
| Price / NCAV | -1.94 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.08 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.91 |
| Current Ratio | 1.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 28,957.00 |
| Assets | 148,858.00 |
| Liabilities | 135,281.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Capital Research Global Investors | 2.10 | -56.21 | |
| 13G/A | Vanguard Group Inc | 8.08 | 16.31 | |
| 13G/A | BlackRock Inc. | 7.00 | 26.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 561,198 | 3,514,385 | 15.97 | |
| 1,133,644 | 3,643,261 | 31.12 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| ABT – Abbott Laboratories | ADCT – Adc Telecommunications Inc |
Financial data and stock pages provided by
Fintel.io
